Tourmaline Bio, Inc. (TRML)

Tourmaline Bio Statistics

Total Valuation

Tourmaline Bio has a market cap or net worth of $570.80 million. The enterprise value is $321.69 million.

Market Cap	570.80M
Enterprise Value	321.69M

Important Dates

The last earnings date was Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Tourmaline Bio has 25.69 million shares outstanding. The number of shares has increased by 53.98% in one year.

Current Share Class	25.69M
Shares Outstanding	25.69M
Shares Change (YoY)	+53.98%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	8.35%
Owned by Institutions (%)	63.39%
Float	13.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.04
P/TBV Ratio	2.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-20.70%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.20M
Employee Count	74
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +58.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+58.15%
50-Day Moving Average	18.98
200-Day Moving Average	18.61
Relative Strength Index (RSI)	62.89
Average Volume (20 Days)	211,141

Short Selling Information

The latest short interest is 2.63 million, so 10.24% of the outstanding shares have been sold short.

Short Interest	2.63M
Short Previous Month	3.01M
Short % of Shares Out	10.24%
Short % of Float	18.89%
Short Ratio (days to cover)	13.99

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-102.45M
Pretax Income	-35.69M
Net Income	-88.47M
EBITDA	-102.41M
EBIT	-102.45M
Earnings Per Share (EPS)	-$3.44

Balance Sheet

The company has $249.31 million in cash and $196,000 in debt, giving a net cash position of $249.11 million or $9.70 per share.

Cash & Cash Equivalents	249.31M
Total Debt	196,000
Net Cash	249.11M
Net Cash Per Share	$9.70
Equity (Book Value)	279.86M
Book Value Per Share	10.90
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Tourmaline Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.98%
Shareholder Yield	-53.98%
Earnings Yield	-15.50%
FCF Yield	n/a

Analyst Forecast

The average price target for Tourmaline Bio is $49.33, which is 122.01% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$49.33
Price Target Difference	122.01%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	0.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a